Cargando…
Trypanosoma cruzi STIB980: A TcI Strain for Drug Discovery and Reverse Genetics
Since the first published genome sequence of Trypanosoma cruzi in 2005, there have been tremendous technological advances in genomics, reverse genetics, and assay development for this elusive pathogen. However, there is still an unmet need for new and better drugs to treat Chagas disease. Here, we i...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610277/ https://www.ncbi.nlm.nih.gov/pubmed/37887733 http://dx.doi.org/10.3390/pathogens12101217 |